YD Bio Ltd revenue

YD Bio Ltd's revenue was $596,817 in fiscal 2025, up 16.9% on the year before.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

YD Bio Ltd: revenue history, annual
Fiscal year	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	350	510	597
Growth on the year before	—	+45.8%	+16.9%
Gross profit	153	155	167
Gross margin	43.8%	30.4%	28.1%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Life Sciences Tools & Services: the closest covered companies by revenue. Last twelve months.

Company	Revenue	Growth	3-year growth a year
YD Bio Ltd	$596,817	16.9%	—
Ispecimen Inc.	$466,302	-92.1%	-64.1%
Quantum-si Inc	$1.6m	-53.0%	51.8%
Bionexus Gene Lab Corp	$3.1m	-67.3%	-32.9%
Aclarion, Inc.	$83,769	33.1%	0.2%
Seer, Inc.	$14.2m	-12.7%	-5.1%

Compare with peers

Head to head: ISPC vs YDES QSI vs YDES BGLC vs YDES ACON vs YDES

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from YD Bio Ltd's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to YD Bio Ltd.